![]() |
市场调查报告书
商品编码
1949487
雷射捕捉显微切割市场 - 全球产业规模、份额、趋势、机会及预测(按产品、系统类型、应用、最终用户、地区和竞争格局划分,2021-2031年)Laser Capture Microdissection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By System Types, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球雷射捕获晶粒市场预计将从 2025 年的 1.8546 亿美元增长到 2031 年的 3.3161 亿美元,复合年增长率达到 10.17%。
这项技术对于从组织样本中分离特定细胞并进行详细的分子分析至关重要,其发展得益于精准医疗的日益普及以及肿瘤学研究中对细胞学检测的需求。慢性病盛行率的上升进一步推动了这一成长趋势,因为它催生了对专业基因组分析工具的需求。例如,美国癌症协会估计,到2024年,美国新增癌症病例将首次超过200万例,凸显了解决复杂健康问题对精准研究设备的迫切需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 1.8546亿美元 |
| 市场规模:2031年 | 3.3161亿美元 |
| 复合年增长率:2026-2031年 | 10.17% |
| 成长最快的细分市场 | 软体和服务 |
| 最大的市场 | 北美洲 |
市场扩张的一大障碍是这些系统的购买和维护成本高。高额的投资使得雷射捕获晶粒技术主要局限于资金雄厚的製药公司和研究机构,从而限制了预算有限的小规模实验室采用该技术,并阻碍了这项先进技术在科学界的广泛应用。
生命科学研发领域投资的不断成长正成为全球雷射捕获晶粒市场的主要推动力。各国政府和私人机构纷纷向基因组学研究投入大量资金,而基因组学研究则需要精准的样本分离技术。例如,英国政府于2024年3月宣布投资3.6亿英镑,以加强生命科学领域的製造业,从而推动太空体学分析所需高成本技术的应用。这项需求也反映在10x Genomics公司的表现上,该公司2024年2月的营收达到6.187亿美元。这一增长主要得益于空间生物学平台的广泛应用,而这些平台通常需要组织晶粒样本。
癌症和慢性疾病的日益增多进一步推动了雷射捕获晶粒技术在揭示复杂疾病机制方面的应用。肿瘤学研究高度依赖这项技术将癌细胞与其周围环境分离,以实现精准的生物标记发现。世界卫生组织(WHO)的预测也凸显了此类精准工具的迫切性。 2024年2月,世卫组织预测,到2050年,新增癌症病例将超过3,500万例。患者数量的激增促使製药公司加快药物研发进程,并推广晶粒的应用,以确保用于关键基因组分析的生物样本纯度。
购置和维护雷射捕获晶粒系统所需的大量资本投入是限制市场扩张的主要阻碍因素。这些仪器包含复杂的光学和雷射组件,导致初始成本高昂,实际上将资源有限的小规模学术实验室和研究中心拒之门外。此外,持续的专业维护、专用耗材和技术培训成本也会造成长期的财务负担,阻碍预算紧张的机构采用这些系统。因此,基本客群主要集中在顶尖研究机构和製药公司。
公共资金的波动进一步加剧了这一财务障碍,许多实验室依赖公共资金购买设备。根据美国科学促进会(AAAS)2024年的预测,在最终联邦预算中,美国国立卫生研究院(NIH)的拨款减少了0.8%,直接限制了可用于科学研究设备购置的资金。资源的缩减迫使各机构延后或取消高成本分析设备的采购。当实验室面临此类预算限制时,它们无法获得昂贵仪器设备的津贴,这直接导致全球雷射捕获晶粒市场成长速度放缓。
雷射捕获晶粒与质谱联用技术在深度可视化蛋白质组学领域的应用,透过将高解析度显微镜与深度分子分析相结合,正在重塑市场格局。这项先进的工作流程利用人工智慧驱动的影像分析来指导晶粒,使研究人员能够分离特定的细胞表型,进行超灵敏的下游质谱分析。与传统的整体分析不同,该技术能够在保留空间资讯的同时,对蛋白质组进行深度定量,这对于阐明肿瘤异质性等复杂的疾病机制至关重要。布鲁克公司2025年3月发布的报告反映了此类整合解决方案的商业性成功,该报告预测,在太空生物学和蛋白质组学领域的业务扩张推动下,公司营收将超过33亿美元。
同时,为满足大规模临床研究和生物银行的需求,自动化高通量晶粒系统的研发正蓬勃发展。现代实验室正逐步抛弃人工操作,转而采用利用模式识别软体快速、可重复地识别和切除目标细胞的自动化平台。这一趋势的驱动力在于,需要对高维分析技术的样品製备进行标准化,以确保数千个样品的数据品质一致。 Standard Biotools截至2025年2月的财政年度财务表现也印证了这项生物工作流程产业化的趋势。该公司公布的年收入为1.751亿美元,并强调了其在支持可扩展基因组应用工具方面的持续投入。
The Global Laser Capture Microdissection Market is projected to expand from USD 185.46 Million in 2025 to USD 331.61 Million by 2031, achieving a CAGR of 10.17%. This technology is essential for isolating specific cells from tissue samples to enable detailed molecular analysis, and its growth is being driven by a heightened focus on precision medicine and the necessity for cellular examination in oncology research. The rising prevalence of chronic diseases further supports this trajectory, as it creates a demand for specialized genomic profiling tools. For example, the American Cancer Society estimated in 2024 that new cancer cases in the United States would exceed 2 million for the first time, emphasizing the urgent need for precise research instruments to tackle complex health issues.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 185.46 Million |
| Market Size 2031 | USD 331.61 Million |
| CAGR 2026-2031 | 10.17% |
| Fastest Growing Segment | Software and Services |
| Largest Market | North America |
A significant barrier to market expansion is the substantial cost involved in purchasing and maintaining these systems. The high financial investment required limits the accessibility of laser capture microdissection technology primarily to well-funded pharmaceutical companies and research institutions. Consequently, adoption among smaller laboratories with tighter budgets is restricted, which hinders the broader reach and utilization of this advanced technology within the scientific community.
Market Driver
Increased investment in life science research and development acts as a major catalyst for the Global Laser Capture Microdissection Market, with governments and private entities channeling significant funds into genomic studies that require precise sample isolation. For instance, in March 2024, the UK Government announced a £360 million commitment to boost manufacturing in the life sciences sector, enabling laboratories to purchase high-cost technologies necessary for spatial omics. This demand is further evidenced by 10x Genomics, which reported revenue of $618.7 million in February 2024, driven by the strong adoption of spatial biology platforms that frequently rely on microdissected tissue inputs.
The growing prevalence of cancer and chronic diseases further compels the adoption of laser capture microdissection to elucidate complex disease mechanisms. Oncology research depends heavily on this technology to separate tumor cells from their surrounding environment, allowing for accurate biomarker discovery. The urgency for such precision tools is highlighted by global health projections; in February 2024, the World Health Organization predicted that new cancer cases would rise to over 35 million by 2050. This increasing patient burden drives pharmaceutical companies to accelerate drug discovery pipelines, thereby boosting the utilization of microdissection to ensure the purity of biological samples in critical genomic assays.
Market Challenge
The significant capital expenditure required to acquire and maintain laser capture microdissection systems serves as a primary restraint on market expansion. These instruments contain complex optical and laser components that result in high initial prices, effectively excluding smaller academic laboratories and research centers with limited funding. Furthermore, the recurring costs associated with specialized maintenance, proprietary consumables, and technical training create a long-term financial burden that discourages adoption among budget-constrained entities, leaving the customer base concentrated within elite research institutions and pharmaceutical companies.
This financial barrier is aggravated by fluctuations in public funding, which many laboratories depend on for capital equipment purchases. According to the American Association for the Advancement of Science in 2024, the finalized federal budget reduced funding for the National Institutes of Health by 0.8 percent, directly constraining the purchasing power available for research instrumentation. This contraction in resources forces institutions to delay or cancel the procurement of high-cost analytical tools. When laboratories face such fiscal tightening, the inability to secure grants for expensive machinery directly results in a slower growth rate for the global laser capture microdissection market.
Market Trends
The integration of laser capture microdissection with mass spectrometry for Deep Visual Proteomics is reshaping the market by bridging high-resolution microscopy with detailed molecular profiling. This advanced workflow uses artificial intelligence-driven image analysis to guide microdissection, enabling researchers to isolate specific cell phenotypes for ultra-sensitive downstream mass spectrometry. Unlike traditional bulk analysis, this approach preserves spatial context while allowing for deep quantification of the proteome, which is vital for understanding complex disease mechanisms such as tumor heterogeneity. The commercial success of such integrated solutions is reflected in Bruker Corporation's March 2025 report, which showed revenues exceeding $3.3 billion, partly attributed to its expansion in spatial biology and proteomics.
Simultaneously, the development of automated and high-throughput microdissection systems is gaining traction to meet the demands of large-scale clinical studies and biobanking. Modern laboratories are moving away from manual techniques in favor of automated platforms that leverage pattern recognition software to identify and excise target cells with high speed and reproducibility. This trend is driven by the need to standardize sample preparation for high-dimensional analysis technologies, ensuring consistent data quality across thousands of samples. This push toward industrialized biological workflows is evident in Standard BioTools' February 2025 financial results, where the company reported a full-year revenue of $175.1 million, underscoring the sustained investment in tools that support scalable genomic applications.
Report Scope
In this report, the Global Laser Capture Microdissection Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Laser Capture Microdissection Market.
Global Laser Capture Microdissection Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: